Pharmaceutical Executive
The key steps to easing rising complexity and cost factors.
Jason Evers
Advertisement
Articles by Jason Evers
Advertisement
Latest Updated Articles
Reducing the Risk of NoncomplianceFebruary 8th 2017
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
5